ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 375 filers reported holding ASTRAZENECA PLC in Q1 2015. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,522,528 | +68.7% | 57,989 | +46.5% | 0.20% | +63.1% |
| Q1 2024 | $2,681,371 | +1552.4% | 39,577 | +1542.9% | 0.12% | +1425.0% |
| Q4 2023 | $162,275 | +35.8% | 2,409 | +36.6% | 0.01% | +14.3% |
| Q3 2023 | $119,486 | -36.9% | 1,764 | -33.4% | 0.01% | -30.0% |
| Q2 2023 | $189,476 | +6.4% | 2,647 | +3.2% | 0.01% | 0.0% |
| Q1 2023 | $178,038 | +33.8% | 2,565 | +30.7% | 0.01% | +25.0% |
| Q4 2022 | $133,024 | +24.3% | 1,962 | 0.0% | 0.01% | +14.3% |
| Q3 2022 | $107,000 | -30.1% | 1,962 | -15.1% | 0.01% | -22.2% |
| Q2 2022 | $153,000 | -13.6% | 2,312 | -13.1% | 0.01% | 0.0% |
| Q1 2022 | $177,000 | +0.6% | 2,662 | -11.6% | 0.01% | +12.5% |
| Q4 2021 | $176,000 | -14.1% | 3,012 | -11.7% | 0.01% | -27.3% |
| Q3 2021 | $205,000 | -16.0% | 3,412 | -16.0% | 0.01% | -15.4% |
| Q2 2021 | $244,000 | +17.9% | 4,062 | -2.4% | 0.01% | +8.3% |
| Q1 2021 | $207,000 | -2.8% | 4,162 | -2.2% | 0.01% | -7.7% |
| Q4 2020 | $213,000 | -7.4% | 4,254 | +1.5% | 0.01% | -18.8% |
| Q3 2020 | $230,000 | +19.2% | 4,192 | +15.0% | 0.02% | +14.3% |
| Q2 2020 | $193,000 | +17.7% | 3,645 | -0.6% | 0.01% | -6.7% |
| Q1 2020 | $164,000 | -7.3% | 3,667 | +3.7% | 0.02% | +15.4% |
| Q4 2019 | $177,000 | +13.5% | 3,535 | +1.0% | 0.01% | +8.3% |
| Q3 2019 | $156,000 | +5.4% | 3,500 | -2.4% | 0.01% | 0.0% |
| Q2 2019 | $148,000 | +2.1% | 3,585 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $145,000 | +6.6% | 3,585 | 0.0% | 0.01% | -7.7% |
| Q4 2018 | $136,000 | +33.3% | 3,585 | +38.7% | 0.01% | +62.5% |
| Q3 2018 | $102,000 | -13.6% | 2,585 | -22.8% | 0.01% | -20.0% |
| Q2 2018 | $118,000 | -29.8% | 3,350 | -30.1% | 0.01% | -33.3% |
| Q1 2018 | $168,000 | -9.2% | 4,790 | -10.0% | 0.02% | -11.8% |
| Q4 2017 | $185,000 | +9.5% | 5,323 | +6.7% | 0.02% | +6.2% |
| Q3 2017 | $169,000 | -24.9% | 4,989 | -24.4% | 0.02% | -27.3% |
| Q2 2017 | $225,000 | +9.8% | 6,600 | 0.0% | 0.02% | +10.0% |
| Q1 2017 | $205,000 | -14.6% | 6,600 | -24.9% | 0.02% | -20.0% |
| Q4 2016 | $240,000 | +29.7% | 8,790 | +55.9% | 0.02% | +25.0% |
| Q3 2016 | $185,000 | -7.0% | 5,640 | -14.5% | 0.02% | -13.0% |
| Q2 2016 | $199,000 | +53.1% | 6,600 | +43.5% | 0.02% | +53.3% |
| Q1 2016 | $130,000 | -16.7% | 4,600 | 0.0% | 0.02% | -16.7% |
| Q4 2015 | $156,000 | +6.8% | 4,600 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $146,000 | -0.7% | 4,600 | +100.0% | 0.02% | +5.9% |
| Q2 2015 | $147,000 | -8.1% | 2,300 | -1.7% | 0.02% | -10.5% |
| Q1 2015 | $160,000 | +5233.3% | 2,340 | +5750.0% | 0.02% | – |
| Q4 2014 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q2 2014 | $3,000 | -87.5% | 40 | -89.9% | 0.00% | -100.0% |
| Q4 2013 | $24,000 | +14.3% | 396 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $21,000 | +10.5% | 396 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $19,000 | – | 396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |